Geron
GERN
#6229
Rank
NZ$1.45 B
Marketcap
NZ$2.28
Share price
0.00%
Change (1 day)
-55.53%
Change (1 year)

Earnings for Geron (GERN)

Earnings in 2025 (TTM): -NZ$79.82 Million

According to Geron's latest financial reports the company's current earnings are NZ$0.18 Billion. In 2024 the company made an earning of -NZ$0.26 Billion, an increase over its 2023 earnings that were of -NZ$0.3 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Geron from 1996 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -NZ$79.82 Million-69.21%
2024 -NZ$0.26 Billion-11.23%
2023 -NZ$0.3 Billion30.22%
2022 -NZ$0.23 Billion20.15%
2021 -NZ$0.19 Billion50.08%
2020 -NZ$0.13 Billion4.46%
2019 -NZ$0.12 Billion130.68%
2018 -NZ$51.62 Million8.84%
2017 -NZ$47.42 Million-3.08%
2016 -NZ$48.93 Million-22080.6%
2015 NZ$0.22 M-100.38%
2014 -NZ$59.12 Million-7.14%
2013 -NZ$63.66 Million
2011 -NZ$0.16 Billion19.04%
2010 -NZ$0.13 Billion8.45%
2009 -NZ$0.12 Billion-2.51%
2008 -NZ$0.12 Billion14.65%
2007 -NZ$0.11 Billion32.68%
2006 -NZ$78.67 Million25.59%
2005 -NZ$62.64 Million4.36%
2004 -NZ$60.03 Million19.73%
2003 -NZ$50.13 Million-15.46%
2002 -NZ$59.3 Million1.94%
2001 -NZ$58.17 Million33.59%
2000 -NZ$43.54 Million27.53%
1999 -NZ$34.15 Million63.13%
1998 -NZ$20.93 Million15.6%
1997 -NZ$18.11 Million-10.66%
1996 -NZ$20.27 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Gilead Sciences
GILD
NZ$16.42 B-21,626.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Incyte
INCY
NZ$2.63 B-3,558.39%๐Ÿ‡บ๐Ÿ‡ธ USA
CTI BioPharma
CTIC
-NZ$0.12 Billion 50.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Techne
TECH
NZ$0.19 B-351.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
-NZ$15.77 Million-79.34%๐Ÿ‡บ๐Ÿ‡ธ USA